Načítá se...
Therapeutic monitoring of amikacin and gentamicin in critically and noncritically ill patients
OBJECTIVE: Therapeutic drug monitoring (TDM) enables individualization in the treatment to optimize clinical benefit and minimize drugs' side effects. Critically ill septic patients represent a challenge for antimicrobial treatment because of pathophysiological impact of sepsis on pharmacokinet...
Uloženo v:
| Vydáno v: | J Basic Clin Pharm |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medknow Publications & Media Pvt Ltd
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4910469/ https://ncbi.nlm.nih.gov/pubmed/27330257 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-0105.183260 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|